ABSTRACT 8-Azido[2-3H]adenine was used as a photoaffinity label for the purine-cytosine transport system. After irradiation in the presence of the photoaffinity label, the cells were converted into protoplasts, their plasma membranes were purified, and the membrane proteins were extracted and separated by NaDodSO4/PAGE. The radioactivity was specifically incorporated into a protein with a molecular weight of 120,000. The uptake of the purine bases adenine, guanine, and hypoxanthine and the pyrimidine base cytosine in Saccharomyces cerevisiae is catalyzed by a single energy-dependent transport system (1, 2). In vivo properties of the transport system such as genetic characterization, energy coupling, and a possible mechanism of substrate binding to the purine-cytosine transport system are described in refs. 3-6.
incorporated into a protein with a molecular weight of 120,000. Photoaffinity labeling of this protein could be blocked by irradiation in the presence of natural substrates for the transport system. The molecular weight as determined by NaDod-S04/PAGE was found to be twice the value calculated from mRNA analysis of the cloned gene. Incubation of exponentially growing cells with tunicamycin, an antibiotic that inhibits glycosylation of proteins, resulted in a 40% decrease in the overall initial uptake rate, which correlates with the reduction of the labeled Mr 120,000 protein. Treatment of the extracted labeled plasma membrane proteins with glycosidic enzymes resulted in disappearance of the Mr 120,000 peak and the appearance of new peaks at Mr 60,000 and Mr 73,000. These findings indicate that the purine-cytosine transport protein is a glycoprotein.
The uptake of the purine bases adenine, guanine, and hypoxanthine and the pyrimidine base cytosine in Saccharomyces cerevisiae is catalyzed by a single energy-dependent transport system (1, 2) . In vivo properties of the transport system such as genetic characterization, energy coupling, and a possible mechanism of substrate binding to the purine-cytosine transport system are described in refs. 3-6. For the further characterization of the transport system, we found 8-azidoadenine to be a suitable photoaffinity label. It has a high affinity (Km = 9 x 10-6 M) without being translocated and it is bound covalently to the transport protein on irradiation with UV light. Its synthesis and properties are described in ref. 7 .
The purine-cytosine transport system was cloned on a multicopy plasmid that can replicate autonomously in yeast or in Escherichia coli. Cloning was necessary to (i) increase the amount of transport protein in the yeast plasma membrane, (ii) allow measurement of the length of the mRNA transcript of the cloned gene, and (iii) enable sequencing of the gene.
In this work, we used 8-azido [2-3H] adenine as a photoaffinity label. The transport protein was labeled in vivo, the plasma membranes of the labeled cells were purified by using cationic silica microbeads (8) , and the plasma membrane proteins were extracted for further characterization.
MATERIALS AND METHODS
Strains and Culture Conditions. S. cerevisiae RXII (a gift of A. Kotyk, Prague) was used as the diploid wild-type strain. The mutant strain NC117spl (a leu2 adel fcy2-3) was obtained by a cross of NC99spl (a adel fcy2-3) (a derivative of FL100; ATCC 28383) x GRF18 (his3 leu2). The strains were cultivated in GYNP medium (2% glucose/1% Difco yeast nitrogen base/0.5% peptone) containing hypoxanthine at 10 ,g/ml at 30°C with agitation.
When cells from the stationary growth phase were prepared for maximum uptake, a 50-ml culture was preincubated in 250 ml of glucose/citrate buffer (50 mM sodium citrate, pH 5.5/2% glucose) at 30°C under aeration for 60 min.
To transform E. coli, strain BJ5183 (F-recBC sbcB endoI gal met str hsdR thi bio) was used as receptor strain.
Cloning Procedure. Cloning was accomplished by using two yeast gene libraries, the construction of which is described by Losson and Lacroute (9) . The plasmid used as a vector was pJDB207. In addition to two distinct origins of DNA replication, one of which is functional in E. coli and the other, in yeast, it contains the yeast LEU2 gene and the genes conferring ampicillin and tetracycline resistance to E. coli (10) . The yeast strain NC117spl (a leu2 adel fcy2-3) was used as recipient in yeast transformation. Because of their fcy2 mutation, ade -/leu+ -transformed cells (except those having recovered a functional purine-cytosine transport protein) are unable to grow in the presence of low concentrations (3 ,g/ml) of hypoxanthine.
DNA Preparation and Analysis. Plasmid DNA from E. coli was prepared according to Clewell (11) . Yeast DNA preparation was carried out as described (12) . Restriction endonuclease digestion, filling of protruding ends, and ligation of DNA were carried out as suggested by the suppliers.
Transformation. Yeast was transformed by the method of Hinnen et al. (13) , except that Zymolase 60,000 at a final concentration of 50 ,ug/ml was used to prepare the spheroplasts. E. coli was transformed by the method of Cohen et al. (14) .
Measurement of the Initial Rate of Uptake for Purine Bases. Initial uptake rates were measured as in ref. 6 Photoaffinity Labeling. Cells were harvested in the early exponential phase of growth, washed once with distilled water, and then suspended in ice-cold distilled water (1 x 108 cells per ml). One milliliter of this cell suspension was pipetted into a glass dish (diameter, 5.5 cm), which was placed in an ice bath on a magnetic stirrer. 8-Azido [2- 3H]adenine was added to a final concentration of 0.5 ,tM. For testing the inhibitory effect of natural substrates of the purine-cytosine transport system on specific binding of the photoaffinity label, these substrates were added in thousandfold molar excess to the reaction mixture prior to irradiation. After 5 min of incubation, the cell suspension was frozen by pouring liquid nitrogen over it. The glass dish was then transferred to an ethanol/dry ice bath. The sample was irradiated for 5 min (1.9 mW/cm2) with a UVS-54 Mineralight lamp (emission maximum, 254 nm). Thereafter the sample was quickly thawed and the cells were separated from the incubation mixture by filtration. The whole procedure was carried out in the dark.
Plasma Membrane Isolation. Plasma membranes were isolated and purified as described in ref. 8 . The cells were converted into protoplasts and their plasma membranes were coated with cationic silica microbeads. After lysis, the plasma membranes were washed free of other cell organelles. NaDodSO4/PAGE. Electrophoresis was carried out as described by Laemmli (15) . After photoaffinity labeling, the plasma membrane obtained from 4 x 108 cells was incubated for 5 min at 100'C in denaturation buffer [5% (wt/vol) NaDodSO4/5% (vol/vol) 2-mercaptoethanol/10 mM Tris HCl, pH 8] . After 5 min of centrifugation at 10,000 x g, the denaturated plasma membrane proteins in the supernatant were electrophoresed together with 14C-labeled molecular weight standards using a 3-mm 8% slab gel.
After the run, the gel was cut into 2-mm strips, which were immediately placed to 10 ml of 3% (vol/vol) Protosol (17) .
Glycosidic Enzyme Treatment. Plasma membrane isolated from 8 x 108 cells after photoaffinity labeling was incubated for 2 min in 10% NaDodSO4 at 100°C. After 5 min of centrifugation at 10,000 x g, the supernatant containing the extracted plasma membrane proteins was dialyzed for 2 hr against distilled water to remove the NaDodSO4. Thereafter, the sample was freeze-dried. The resulting protein pellet was suspended in 1 A restriction map of the 6.9-kb fragment is shown in Fig.  1 . Several fragments were subcloned in the vector pJDB207 and tested for their complementation ability in strain NC117spl. Fragments B and C (plasmids pX and pAB) with 2.9-and 2.6-kb inserts, respectively, complemented the uptake deficiency of the recipient strain whereas fragment A (plasmid pZ) did not ( Table 1) . Restoration of hypoxanthine uptake activity in the recipient strains could be the result of (i) introduction as a multicopy element of a transport protein distinct from the purine-cytosine transport system in which low affinity is balanced by high copy number, (ii) cloning of a suppressor gene, and (iii) cloning of the true purine-cytosine transport protein gene FCY2.
The first possibility is ruled out by the fact that strains containing the cloned gene exhibit the same substrate specificity and Km values as the wild type (Table 2) . Similarly, the increase in Vmax by a factor of 3 above the wild-type level makes the cloning of a suppressor gene unlikely. To confirm this interpretation, the yeast strain NC203spl (a ura3-373-251-328 fcy2-3) was transformed by an integrating plasmid made of pBR322, the yeast gene URA3, and the yeast DNA fragment D, which contains the region complementing the purine-cytosine permease deficiency (Fig. 1) . The use of a ura3 recipient strain with three mutations scattered in the gene eliminated the recovery of prototrophic colonies resulting from integration at the URA3 locus. Moreover, to enhance the integration frequency and to direct it to the chromosomal region homologous to fragment D, the plasmid was linearized (18) using the restriction enzyme Bgl II (Fig. 1) . Three clones transformed to uracil prototrophy and purinecytosine permease proficiency were then crossed with strain FL480-1D (afcy2-3). Eleven tetrads were analyzed and gave a 2:2 segregation for the fcy2-3 allele whereas eight uracil auxotrophs were recovered. This shows unambigously that the D fragment had integrated at the FCY2 locus. Therefore, we conclude that the cloned DNA fragment contains the complete FCY2 gene coding for the purine-cytosine transport system and that this gene is situated in the C region.
Localization of the Gene Within the Cloned DNA Fragment. To define the position of the gene within the C fragment of plasmid pAB, the HindIII sites of this segment were modified one by one by filling with complementary base pairs the 5' protruding ends of DNA that had been partially digested with HindIII. The DNA was circularized with T4 DNA ligase and used to transform E. coli to ampicillin resistance. The plasmid structure of ampicillin-resistant colonies was determined. A leu2 fcy2-18 yeast strain was then transformed to prototrophy with the modified plasmids and purine-cytosine 3 1,900 pAQ4 filling at site 3 120,380 Strain NC201sp2 (a leu2-1 fcy2-18) was used as recipient for the various plasmids. Initial rate of cytosine uptake was measured using 4 gM [14C]cytosine with a specific radioactivity of 5 mCi/mol. permease activity was scored by measuring both cytosine uptake velocity (Table 3 ) and resistance to 5-fluorocytosine. Destruction of the HindI11 site 1 completely abolished the uptake of cytosine (plasmid pAQ35), giving resistance to 5-fluorocytosine similar to that of a strain with the fcy2-18 mutation. On the other hand, modification of the HindIII site 3 (pAQ4) did not lead to any change relative to pAB. When the HindIII site 2 was destroyed (pAQ56) or when the short DNA fragment spanning from the HindIII site 2 to site 3 was deleted (pAQSS), cytosine uptake was significant but well below the level found for pAB or pAQ4. Also the resistance to 5-fluorocytosine was intermediate between those of the wild-type and fcy2-mutated strains. These results show that the HindIII site 1 is located within the FCY2 gene whereas the HindIII site 3 is situated outside. As modifications at the HindIII site 2 reduce the uptake velocity by a factor of 50, this site is likely located near one end of the gene either in the coding region or in a region that modulates FCY2 gene expression. Therefore, the DNA fragment that extends from the HindIII site 1 to the HindIlI site 2 is a valuable probe for hybridization to the mRNA that codes for the purine-cytosine transport protein.
Photoafflinity Labeling. For the specific photoaffinity labeling of the transport protein, cells in the exponential phase of growth were irradiated in the presence of 0.5 ,uM 8-azido [2-3H] adenine. To distinguish between specific and nonspecific binding of the photoaffinity label, other natural substrates for the purine-cytosine transport system were added (final concentration, 0.5 mM) to the reaction mixture prior to irradiation.
After photoaffinity labeling, the plasma membrane was purified and the proteins were extracted. For a better com- -Proc. Nati. Acad. Sci. USA 81 (1984) parison, samples from different experiments were electrophoresed on the same gel (Fig. 2) . Two major peaks of radioactivity were found, one with an apparent molecular weight of 120,000 and the other, of 100,000. The specific labeling of the Mr 120,000 protein was largely blocked when adenine (or another natural substrate of the transport system) was added to the reaction mixture prior to irradiation (Fig. 2) . In contrast, uracil or ATP, pyrimidine or purine derivatives that are not recognized by the transport system, did not interfere with photoaffinity labeling of the Mr 120,000 protein. ATP, however, blocked the labeling of the Mr 100,000 protein, indicating that this protein is not related to purine-cytosine transport. Further support for this conclusion was derived from another control experiment in which 8-azidoadenine was replaced by 8-azidoadenosine, which does not affect the uptake of purine bases or cytosine. In this case, the Mr 100,000 protein was labeled whereas the Mr 120,000 protein was not.
mRNA Analysis. The mRNA of the cloned gene was identified by hybridization of the HindIll site 1-site 2 gene fragment to a cellular RNA blot. As shown in Fig. 3 , only one band, which represents the mRNA of the cloned gene, is visualized. Its size of 1.9 kb corresponds to a protein with a molecular weight of about 73,000.
To explain the different molecular weights for the purinecytosine transport protein obtained by NaDodSO4/PAGE and by mRNA analysis, we considered the possibility that the transport protein is a glycoprotein and that its carbohydrate moiety is responsible for the difference. A set of experiments was performed to check for this possibility. Wild-type yeast RNA was extracted, denatured, blotted to nitrocellulose paper, and hybridized to a 32P-labeled DNA probe. The DNA probe was the 1-kb HindIll fragment (Fig. 1) The distribution of radioactivity after NaDodSO4/PAGE of photoaffinity-labeled plasma membrane proteins extracted from the same number of cells before and after incubation with tunicamycin is shown in Fig. 4 . The total amount of labeled Mr 120,000 protein after tunicamycin treatment was reduced by about the same extent as the initial uptake rate in the first experiment.
To separate the purine-cytosine transport protein from its carbohydrate moiety, we incubated the extracted plasma membrane proteins after photoaffinity labeling with a mixture of glycosidic enzymes. As shown in Fig. 4 , after this treatment, NaDodSO4/PAGE separation resulted in complete loss of the Mr 120,000 protein whereas the Mr 100,000 protein was unaffected and two previously unobserved labeled proteins appeared at Mr values of 60,000 and 73,000.
DISCUSSION
It has previously been shown that 8-azidoadenine binds covalently to the purine-cytosine transport system on UV irradiation (7). It was therefore tempting to use the radioactive compound for further characterization. Commercially available 8-azido [2-3H] adenosine offers a suitable starting material for obtaining 8-azido [2-3H] adenine by acid hydrolysis. We obtained high enough photoaffinity labeling to detect the protein after NaDodSO4/PAGE by (i) using a mutant with the cloned transport system; (ii) labeling the cells in the frozen state, which increases the specific labeling (7, 20) ; and using a highly efficient procedure for purification of the plasma membrane [yield, =90% (8) Two plasma membrane proteins are labeled by azidoadenine above the background level, one with a molecular weight of 120,000, the other of Mr 100,000. Only the Mr 120,000 protein can be protected against labeling by a variety of natural substrates: adenine, guanine, hypoxanthine, and cytosine (Fig. 2) . Since no other protein is known to exhibit the same pattern of specificity, we conclude that the Mr 120,000 protein is actually the purine-cytosine transport protein. This conclusion is supported by the fact that uracil, which is closely related to cytosine but not a substrate for the transport system, does not inhibit the labeling (Fig. 2) .
Labeling of the Mr 100,000 protein is prevented by adenine but not by other substrates of the transport system. ATP has the same effect (Fig. 2) . Since nucleotides have no effect on the uptake of purine bases in S. cerevisiae, this protein is not related to the transport protein under investigation.
The discrepancy between the molecular weight of the transport protein as determined by NaDodSO4/PAGE and as derived from mRNA analysis prompted us to investigate whether the labeled Mr 120,000 protein is a glycoprotein. We used tunicamycin, an inhibitor of protein glycosylation and glycosidic enzymes, to test this hypothesis.
The reduction of the overall uptake rate (Fig. 4) found after treatment of exponentially growing cells with tunicamycin could mean that daughter cells are depleted of a functional transport system. This possibility is supported by the finding that, in tunicamycin-treated cells, the total amount of the Mr 120,000 protein labeled by 8-azidoadenine is reduced to an extent that correlates with the decrease in uptake velocity (Fig. 4) . Since no other labeled peak appeared, the Mr 120,000 protein seems to be a glycoprotein of which glycosylation and insertion into the plasma membrane is prevented by the antibiotic.
This hypothesis is further supported by the results obtained with glycosidic enzymes (Fig. 4) . Treatment of photoaffinity-labeled membrane proteins with a mixture of glycosidases leads to the total disappearance of the Mr 120,000 peak but not of the Mr 100,000 peak and to the appearance of new peaks at Mr 60,000 and 73,000. Whereas the Mr 73,000 peak exactly matches the molecular weight deduced from mRNA analysis, the Mr 40,000 peak could be the result of proteolytic activities contaminating the glycosidic enzymes.
The finding that the transport protein is a glycoprotein could also account for the low expression of the cloned gene compared with the expression achieved with the cloned uracil transport protein gene (21) . This hypothesis is further supported by the fact that the total amount of the specific mRNA in a strain containing the cloned purine-cytosine transport protein gene is 20-fold above the level found in wild-type strains (unpublished results). This differs markedly from the results obtained with the cloned uracil permease gene, where a commensurate increase in quantity of the specific mRNA and uracil transport activity was found (21) .
